MDR_REPORT_KEY|MDR_TEXT_KEY|TEXT_TYPE_CODE|PATIENT_SEQUENCE_NUMBER|DATE_REPORT|FOI_TEXT|BRAND_NAME|CATALOG_NUMBER|DATE_RECEIVED|DATE_REMOVED_FLAG|DATE_RETURNED_TO_MANUFACTURER|DEVICE_AGE_TEXT|DEVICE_AVAILABILITY|DEVICE_EVALUATED_BY_MANUFACTUR|DEVICE_EVENT_KEY|DEVICE_OPERATOR|DEVICE_REPORT_PRODUCT_CODE|DEVICE_SEQUENCE_NO|EXPIRATION_DATE_OF_DEVICE|GENERIC_NAME|IMPLANT_FLAG|LOT_NUMBER|MANUFACTURER_D_ADDRESS_1|MANUFACTURER_D_ADDRESS_2|MANUFACTURER_D_CITY|MANUFACTURER_D_COUNTRY_CODE|MANUFACTURER_D_NAME|MANUFACTURER_D_POSTAL_CODE|MANUFACTURER_D_STATE_CODE|MANUFACTURER_D_ZIP_CODE|MANUFACTURER_D_ZIP_CODE_EXT|MODEL_NUMBER|OTHER_ID_NUMBER|filter
6663360|78278940|D|1||PHYSICIAN REPORTED DIAGNOSIS IMPLANT ASSOCIATED CD30-POSITIVE ALK- NEGATIVE ANAPLASTIC LARGE-CELL LYMPHOMA LEFT SIDE CLINICAL STAGE IB DEVICE REMOVED CAPSULECTOMY PERFORMED LYMPH NODE REMOVAL LEFT AXILLA CLINICAL SONOGRAPHIC SUSPICIOUS FINDINGS PLANNED TREATMENT SPECIFIED CLINICAL MONITORING ULTRASOUND CT EVERY 6 MONTHS 2 YEARS ANNUALLY 5 YEARS|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|TSF385|06/23/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
4250989|19765661|D|1||PT RECURRENT RIGHT PERICAPSULAR FLUID BEGINNING B6 2014 CONSTANT DULL PAIN SWELLING DRAINED TWICE PRIOR DATE ULTRASOUND ASPIRATION B6 2014 SPECIMEN APPROXIMATELY 17 ML YELLOW STRAW COLORED WATERY FLUID TISSUE FREE-FLOATING THROUGHOUT SPECIMEN B APPROXIMATELY 10CC YELLOW STRAW-COLORED FLUID TISSUE FREE-FLOATING THROUGHOUT DIAGNOSIS SPECIMEN CYTOLOGY RIGHT BREAST -CD30-POSITIVE MALIGNANT NEOPLASM CYTOSPIN SECTION CELL BLOCK SHOW SHEETS LARGE MALIGNANT CELLS LARGE VESICULAR NUCLEI CONTAINING PUNCTATE PROMINENT NUCLEOLI MODERATE AMOUNTS EOSINOPHILIC CYTOPLASM HALLMARK CELLS IDENTIFIED BATTERY IMMUNOPEROXIDASE STRAINS OBTAINED ORDER CHARACTERIZE CELLS FOLLOWING RESULTS POSITIVE CD30 FINDINGS THOS CD30-POSITIVE MALIGNANT NEOPLASM GIVEN CLINICAL SETTING RECURRENT SEROMAS PT IMPLANTS FINDINGS CONSISTENT ANAPLASTIC LARGE CELL LYMPHOMA PT UNDERWENT REMOVAL IMPLANT IMMEDIATE REPLACEMENT B6 2008 COURSE UNEVENTFUL B6 2014|STYLE 410|410FX|11/04/2014|||||||0HP|FTR|1.0||BREAST IMPLANT||13423996|||GOLETA|US|ALLERGAN|93117|CA|93117||FX-410615||True
6142978|61395223|D|1||LITERATURE ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ REPORTED Â¿19 I-ALCLSÂ¿ CASES ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ ARTICLE REPORTED CASES Â¿INFILTRATIVE I-ALCLÂ¿ SURVIVAL RATE 525 ARTICLE REPORTS CASES RESULTED DEATH TWO LYMPHOMA PROGRESSION RECORD REPRESENTS CASES INFILTRATIVE I-ALCL RESULTED DEATH LYMPHOMA PROGRESSION ARTICLE REPORTS HISTOPATHOLOGY REPORTS MALIGNANT CELLS CD30-POSITIVE ALK NEGATIVE REGARDS TREATMENT ABSTRACT REPORTS Â¿IMPLANT REMOVAL PERFORMED 17 19 PATIENTS ADDITIONAL TREATMENT BASED MOSTLY CHOP CHOP-LIKE CHEMOTHERAPY REGIMENS N = 1019 IRRADIATION N = 119 CHOP ALONE ABVD FOLLOWING RADIATION WITHOUT IMPLANT REMOVAL GIVEN TWO PATIENTSÂ¿ WAY KNOWING TREATMENT USED TWO CASES MANUFACTURER DEVICES UNKNOWN|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/02/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
5620649|44064473|D|1||EXPLANTING PHYSICIAN REPORTED PATIENT TREATED LATE SEROMA ANAPLASTIC LARGE CELL LYMPHOMA ALCL CONTRALATERAL SIDE FINE NEEDLE ASPIRATION BIOPSY CONTRALATERAL SIDE REVEALED FOLLOWING ADDITIONAL DIAGNOSIS CYTOLOGIC FINDINGS COMPATIBLE LYMPH NODE INVOLVEMENT LYMPHOPROLIFERATIVE PROCESS CD30-POSITIVE PROBABLY HODGKINS LYMPHOMA HODGKINS LYMPHOMA SYSTEMIC DISEASE SIDE-SPECIFIC EVENT DIAGNOSTIC TESTING REVEALED NON SIDE-SPECIFIC EVENTS GOITER Â¿LUNG PARENCHYMA MODERATE PARASEPTAL CENTRILOLOBULAR EMPHYSEMA MIDDLE UPPER FIELDSÂ¿ Â¿LAMINAR ATELECTASISÂ¿ APPROXIMATELY ONE MONTH LEFT SIDE ALCL DIAGNOSIS PATIENTS RIGHT SIDE DEVICE REMOVED PHYSICIAN NOTED SURGERY OBSERVED CLINICAL WORSENING PATIENT RESPIRATORY FAILURE SECONDARY LEFT PLEURAL EFFUSION RESULTING ADMISSION ICU THORACIC DRAINAGE RECURRENT CHEST TUBE DRAINAGE REQUIRED 3 OCCASIONS PATIENTS FIRST STAY ICU PATIENT GOES FIRST FLOOR RECEIVES FIRST CYCLE CHEMOTHERAPY SHOWING GRADE IV NEUTROPENIA DIARRHOEA SECOND CHEMOTHERAPY PATIENT SHOWS MARKED CLINICAL DETERIORATION SUSPICIOUS TUMOUR LYSIS SYNDROME METABOLIC ACIDOSIS RENAL FAILURE RESULTS SECOND ADMISSION ICU PATIENT DIED APPROXIMATELY FIVE WEEKS IMPLANT REMOVAL MEDWATCH REPRESENTS RIGHT SIDE SEE MFR  9617229-2016-00035 LEFT SIDE|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM125-320|04/29/2016|||DA|N|R||0HP|FTR|1.0|04/15/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||396184|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6143087|61396767|D|1||ABSTRACT LITERATURE ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ REPORTED Â¿19 I-ALCLSÂ¿ CASES ONE TWO CLINICAL PRESENTATIONS REPORTED Â¿TUMOR MASSÂ¿ 2 PATIENTS EXPERIENCED ALCL MASS RECORD REPRESENTS 2 CASES ALCL PRESENTED TUMOR MASS HISTOPATHOLOGY REPORTS MALIGNANT CELLS CD30-POSITIVE ALK NEGATIVE ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ REGARDS TREATMENT ABSTRACT REPORTS Â¿IMPLANT REMOVAL PERFORMED 17 19 PATIENTS ADDITIONAL TREATMENT BASED MOSTLY CHOP CHOP-LIKE CHEMOTHERAPY REGIMENS N = 1019 IRRADIATION N = 119 CHOP ALONE ABVD FOLLOWING RADIATION WITHOUT IMPLANT REMOVAL GIVEN TWO PATIENTSÂ¿ CURRENTLY WAY DETERMINE TREATMENTS USED 11 CASES MANUFACTURER DEVICES UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/02/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
5620587|44062744|D|1||EXPLANTING PHYSICIAN REPORTED LEFT SIDE ONSET RECURRENT SEROMAS APPROXIMATELY 10 YEARS IMPLANTATION SEROMAS DRAINED THREE OCCASIONS APPROXIMATELY FOUR MONTHS ONSET SEROMAS AXILLARY MASS APPEARED BIOPSIED DIAGNOSIS ANAPLASTIC T-CELL LYMPHOMA ESTABLISHED MULTIPLE ANAPLASTIC CELLS IDENTIFIED SHOWED WEAK CD2 CD3 CD4 EXPRESSION STRONG CD30 TIA-1 PERFORIN EXPRESSION ALK NEGATIVE FINE NEEDLE ASPIRATION BIOPSY REVEALED FOLLOWING ADDITIONAL DIAGNOSIS CYTOLOGIC FINDINGS COMPATIBLE LYMPH NODE INVOLVEMENT LYMPHOPROLIFERATIVE PROCESS CD30-POSITIVE PROBABLY HODGKINS LYMPHOMA DIAGNOSTIC TESTING ADDITIONALLY REVEALED LEFT SIDE LYMPHANGITIS GLOBULAR ADENOPATHIES CAPSULITIS HISTIOCYTES EPITHELIOID ASPECT PART GRANULOMAS PRESENCE LARGE CELLS LARGE AREAS NECROSIS Â¿PERIPROSTHETIC COLLECTIONÂ¿ DIAGNOSTIC TESTING ALSO REVEALED NON SIDE-SPECIFIC EVENTS GOITER Â¿LUNG PARENCHYMA MODERATE PARASEPTAL CENTRILOLOBULAR EMPHYSEMA MIDDLE UPPER FIELDSÂ¿ Â¿LAMINAR ATELECTASISÂ¿ APPROXIMATELY ONE MONTH DIAGNOSIS PATIENT UNDERWENT LEFT SIDE IMPLANT REMOVAL CAPSULECTOMY TOTAL MASTECTOMY LEFT BREAST LIGHT PRESENCE INDURATED BREAST MASS EXTENDING AXILLA PHYSICIAN NOTED IMPLANTS INTACT Â¿THE CAPSULE INTEGRATED TUMOURÂ¿ HISTOLOGIC DIAGNOSIS ANAPLASTIC T-CELL LYMPHOMA RETAINED PHYSICIAN NOTED SURGERY OBSERVED CLINICAL WORSENING PATIENT RESPIRATORY FAILURE SECONDARY LEFT PLEURAL EFFUSION RESULTING ADMISSION ICU THORACIC DRAINAGE RECURRENT CHEST TUBE DRAINAGE REQUIRED 3 OCCASIONS PATIENTS FIRST STAY ICU PATIENT GOES FIRST FLOOR RECEIVES FIRST CYCLE CHEMOTHERAPY SHOWING GRADE IV NEUTROPENIA DIARRHOEA SECOND CHEMOTHERAPY PATIENT SHOWS MARKED CLINICAL DETERIORATION SUSPICIOUS TUMOUR LYSIS SYNDROME METABOLIC ACIDOSIS RENAL FAILURE RESULTS SECOND ADMISSION ICU PATIENT DIED APPROXIMATELY FIVE WEEKS IMPLANT REMOVAL MEDWATCH REPRESENTS LEFT SIDE SEE MFR  9617229-2016-00036 RIGHT SIDE|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM125-320|04/29/2016|||DA|N|R||0HP|FTR|1.0|06/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||306845|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5620587|49100603|D|1||EXPLANTING PHYSICIAN REPORTED LEFT SIDE ONSET RECURRENT SEROMAS APPROXIMATELY 10 YEARS IMPLANTATION SEROMAS DRAINED THREE OCCASIONS APPROXIMATELY FOUR MONTHS ONSET SEROMAS AXILLARY MASS APPEARED BIOPSIED DIAGNOSIS ANAPLASTIC T-CELL LYMPHOMA ESTABLISHED MULTIPLE ANAPLASTIC CELLS IDENTIFIED SHOWED WEAK CD2 CD3 CD4 EXPRESSION STRONG CD30 TIA-1 PERFORIN EXPRESSION ALK NEGATIVE FINE NEEDLE ASPIRATION BIOPSY REVEALED FOLLOWING ADDITIONAL DIAGNOSIS CYTOLOGIC FINDINGS COMPATIBLE LYMPH NODE INVOLVEMENT LYMPHOPROLIFERATIVE PROCESS CD30-POSITIVE PROBABLY HODGKINS LYMPHOMA DIAGNOSTIC TESTING ADDITIONALLY REVEALED LEFT SIDE LYMPHANGITIS GLOBULAR ADENOPATHIES CAPSULITIS HISTIOCYTES EPITHELIOID ASPECT PART GRANULOMAS PRESENCE LARGE CELLS LARGE AREAS NECROSIS Â¿PERIPOSTHETIC COLLECTIONÂ¿ DIAGNOSTIC TESTING ALSO REVEALED NON SIDE-SPECIFIC EVENTS GOITER Â¿LUNG PARENCHYMA MODERATE PARASEPTAL CENTRILOLOBULAR EMPHYSEMA MIDDLE UPPER FIELDSÂ¿ Â¿LAMINAR ATELECTASISÂ¿ APPROXIMATELY ONE MONTH DIAGNOSIS PATIENT UNDERWENT LEFT SIDE IMPLANT REMOVAL CAPSULECTOMY TOTAL MASTECTOMY LEFT BREAST LIGHT PRESENCE INDURATED BREAST MASS EXTENDING AXILLA PHYSICIAN NOTED IMPLANTS INTACT Â¿THE CAPSULE INTEGRATED TUMOURÂ¿ HISTOLOGIC DIAGNOSIS ANAPLASTIC T-CELL LYMPHOMA RETAINED PHYSICIAN NOTED SURGERY OBSERVED CLINICAL WORSENING PATIENT RESPIRATORY FAILURE SECONDARY LEFT PLEURAL EFFUSION RESULTING ADMISSION ICU THORACIC DRAINAGE RECURRENT CHEST TUBE DRAINAGE REQUIRED 3 OCCASIONS PATIENTS FIRST STAY ICU PATIENT GOES FIRST FLOOR RECEIVES FIRST CYCLE CHEMOTHERAPY SHOWING GRADE IV NEUTROPENIA DIARRHOEA SECOND CHEMOTHERAPY PATIENT SHOWS MARKED CLINICAL DETERIORATION SUSPICIOUS TUMOUR LYSIS SYNDROME METABOLIC ACIDOSIS RENAL FAILURE RESULTS SECOND ADMISSION ICU PATIENT DIED APPROXIMATELY FIVE WEEKS IMPLANT REMOVAL MEDWATCH REPRESENTS LEFT SIDE SEE MFR  9617229-2016-00036 RIGHT SIDE|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM125-320|04/29/2016|||DA|N|R||0HP|FTR|1.0|06/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||306845|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6143032|61396907|D|1||ABSTRACT LITERATURE ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ REPORTED Â¿19 I-ALCLSÂ¿ CASES ONE TWO CLINICAL PRESENTATIONS REPORTED Â¿EFFUSIONÂ¿ ELEVEN PATIENTS EXPERIENCED ALCL EFFUSION RECORD REPRESENTS 11 CASES ALCL PRESENTED EFFUSION HISTOPATHOLOGY REPORTS MALIGNANT CELLS CD30-POSITIVE ALK NEGATIVE ARTICLE REPORTED CASES Â¿IN SITU I-ALCLÂ¿ Â¿INFILTRATIVE I-ALCLÂ¿ REGARDS TREATMENT ABSTRACT REPORTS Â¿IMPLANT REMOVAL PERFORMED 17 19 PATIENTS ADDITIONAL TREATMENT BASED MOSTLY CHOP CHOP-LIKE CHEMOTHERAPY REGIMENS N = 1019 IRRADIATION N = 119 CHOP ALONE ABVD FOLLOWING RADIATION WITHOUT IMPLANT REMOVAL GIVEN TWO PATIENTSÂ¿ CURRENTLY WAY DETERMINE TREATMENTS USED 11 CASES MANUFACTURER DEVICES UNKNOWN|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/02/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
